Publications

Below is our bibliography of journal articles, policy briefs, and consortium reports since 2023. For more publications, please view the member profiles.

2026

• Ghafari M, Watson OJ, Dascalu S, Mon SHH, Abeler-Dörner L, Rezaee-Zavareh MS, Pley C, Kordasti S, Abbas K, Madani K, Panovska-Griffiths J. (2026). Global vaccine readiness: equity-by-design in pandemic preparedness and response. Expert Review of Vaccines, 25(1):2732508. https://doi.org/10.1080/14760584.2026.2732508

• Ghafari M, Watson OJ, Dascalu S, Mon SHH, Abeler-Dörner L, Rezaee-Zavareh MS, Pley C, Kordasti S, Abbas K, Madani K, Panovska-Griffiths J. (2026). Best practices in global vaccination roll-out to reduce health inequity. United Nations University Institute for Water, Environment and Health (UNU-INWEH), Richmond Hill, Canada. https://doi.org/10.53328/INP26MAG001 

• Hayashi Y, Abbas K, Dhoubhadel  BG. (2026). Development and analytical characterization of a 24-plex microsphere-based assay for the quantitation of the antibodies against pneumococcal vaccine serotypes. Vaccine, 94, 129266. https://doi.org/10.1016/j.vaccine.2026.129266 

• Tuli A, Jit M, Abbas K, Portnoy A. (2026). Projections of human papillomavirus (HPV) vaccination impact on non-cervical cancer outcomes among women in 117 low- and middle-income countries: a modelling study. BMJ Global Health, 11(8):e021127. https://doi.org/10.1136/bmjgh-2025-021127

• Salaudeen AG, Bolarinwa OA, McGowan CR, Daniel D, Alhaffar M, Abbas K, Adesoro O, Ahmed T, Clarke A, Makunja S, Abdelmagid N, Akande TM. (2026). Assessment of childhood immunisation services in Kano and Lagos States, Nigeria: a mixed-methods study. Health Services Insights, 19. https://dx.doi.org/10.1177/11786329261477836

• Fu H, Sbarra AN, Russell T, Abbas K, Auzenbergs M, Jit M. (2026). Estimating the basic reproduction number of measles in low-and middle-income settings using 172 seroprevalence studies: A modelling approach. PLOS Global Public Health, 6(7):e0006731. https://doi.org/10.1371/journal.pgph.0006731

• Young GT, Kassymova S, Zhang P, Syla S, Clark A, Sadykova T, Sukhanberdiyev K, Abbas K. (2026). Public health impact, cost-effectiveness, and budget impact of HPV vaccination in Kazakhstan: A stakeholder engagement and modelling study. Vaccine: X, 31, 100845. https://doi.org/10.1016/j.jvacx.2026.100845

• Lai X, Abbas K, Pouwels KB, Jit M, Fang H. (2026). Global, regional, and national impact of the Expanded Programme on Immunization against 14 pathogens from 1974 to 2024: an economic evaluation. Lancet Global Health, 103965. https://doi.org/10.1016/j.langlo.2026.103965

• Gaythorpe KAM, Li X, Shankar M, Hartner AM, Gibney Z, Abbas K, Abeysuriya R, Alam C, Auzenbergs M, Azman AS, Barasa E, Costello A, Ferrari MJ, Fraser K, Fu H, Haile L, Kakaï RG, Karachaliou-Prasinou A, Lee EC, Katama EN, Kim JH, Jit M, Liu Y, Malinga J, Moore S, Nayagam S, Nedjati-Gilani G, Okell LC, Onifade AA, Papadopoulos T, Penny MA, Perkins TA, Pitzer VE, Portnoy A, Procter SR, Saraswati CM, Scott N, Seaman C, Shattock AJ, Sim SY, Tran Q, Vynnycky E, Winter AK, Hinsley W, Ferguson NM, Trotter CL. (2026). Quantifying relative health impact across Gavi, the Vaccine Alliance's portfolio in 117 countries at the subregional level: a modelling study. Lancet, 407(10542). https://doi.org/10.1016/s0140-6736(26)00555-6

• Mogasale VV, Zhang P, John J, Farooqui HH, Ray A, Mogasale V, Parry CM, Dhoubhadel BG, Edmunds WJ, Clark A, Abbas K. (2026). Burden of antimicrobial resistance in culture-confirmed Salmonella Typhi isolates in India from 1977 to 2024: A systematic review and meta-analysis. PLOS Neglected Tropical Diseases, 20(4):e0014206. https://doi.org/10.1371/journal.pntd.0014206

• Kitamura N, Kimura T, Morino S, Suzuki M, Cook AR, Abbas K. (2026). Impact and cost-effectiveness of maternal vaccine and short and long-acting monoclonal antibodies against respiratory syncytial virus among children in Japan: A modeling study. Vaccine X, 30:100805. https://doi.org/10.1016/j.jvacx.2026.100805

• Mogasale VV, John J, Ray A, Hasan Farooqui H, Mogasale V, Hutubessy R, Dhoubhadel BG, Edmunds WJ, Clark A, Abbas K. (2026). Economic burden of typhoid fever by antimicrobial resistance in India: a modelling study 2023. Lancet Regional Health - Southeast Asia, 47:100748. https://doi.org/10.1016/j.lansea.2026.100748

• Mogasale VV, John J, Sahai N, Ray A, Hasan Farooqui H, Mogasale V, Dhoubhadel BG, Edmunds WJ, Clark A, Abbas K. (2026). Burden of typhoid fever and antimicrobial resistance in India (2023): a modelling study. Lancet Regional Health - Southeast Asia, 44:100714. https://doi.org/10.1016/j.lansea.2025.100714

2025

• Kang H, Lim A, Clark A, Colón González FJ, Clapham HE, Carrera J, Kim J, Auzenbergs M, Lakshminarayanan P, López-Vergès S, Sim SY, Han SM, Cerqueira-Silva T, Endy T, Cucunubá ZM, Edmunds WJ, Sahastrabuddhe S, Brady OJ, Abbas K. (2025). Age-specific chikungunya outbreak response immunisation strategies in Brazil: a modelling study. eClinicalMedicine, 90:103690. https://doi.org/10.1016/j.eclinm.2025.103690

• Kang H, Lim A, Auzenbergs M, Clark A, Colón-González FJ, Salje H, Clapham H, Carrera JP, Kim JH, Malarski M, López-Vergès S, Cucunubá ZM, Cerqueira-Silva T, Edmunds WJ, Sahastrabuddhe S, Brady OJ, Abbas K. (2025). Global, regional and national burden of chikungunya: force of infection mapping and spatial modelling study. BMJ Global Health, 10(10):e018598. https://doi.org/10.1136/bmjgh-2024-018598

• Kang H, Auzenbergs M, Abbas K, Maure C, Moreno L, Pascale JM, López-Vergès S, Ortega-Barria E, Kim J, Luz K, Warimwe G, Tangkeangsirisin W, Garrido EMR, Robles Y, de Cuellar CM, Vinhal L, Gonzalez-Escobar G, Ozturk M, Dubischar K, Jaramillo JC, Gache CH, Sumathy K, Medina LMH, Bouckenooghe A, Ferguson D, Levis R, Bose R, del Pilar Hernández Svendblad M, Thees MF, Pulgarin SP, Valente B, Viriyabancha W, Esquivel M, Lau E, Samouge C, Porta L, Malarski M, Dinkel KA, Malhame M, de La Hoz F, Chawla T, Sam JIC, Salas I, Di Fabio JL, Bonfanti AAC, Carrera JP, Sahastrabuddhe S. (2025). Stakeholder meeting report: Chikungunya virus – recent outbreaks, vaccine development and the way forward. Vaccine: X, 27:100730. https://doi.org/10.1016/j.jvacx.2025.100730

• Laraj O, Benzina B, Gzara A, Kebir A, Abbas K, BenMiled S. (2025). Potential health impact and cost-effectiveness of human papillomavirus vaccination in Tunisia: a comparative modeling study. Vaccine: X, 27:100712. https://doi.org/10.1016/j.jvacx.2025.100712

• Naylor NR, Hasso-Agopsowicz M, Kim C, Ma Y, Frost I, Abbas K, Aguilar G, Fuller N, Robotham JV, Jit M. (2025) The global economic burden of antibiotic-resistant infections and the potential impact of bacterial vaccines: a modelling study. BMJ Global Health, 10(6):e016249. https://doi.org/10.1136/bmjgh-2024-016249

• Kim C, Frost I, Naylor NR, Au H, Kim Y, Lee Y, Bzymek A, Majgier K, Moldoveanu AL, Salman OM, Simiyu S, Youssef DM, Hasso-Agopsowicz M, Abbas K. (2025) Length of hospital stay and associated treatment costs for patients with susceptible and antibiotic-resistant Salmonella infections: a systematic review and meta-analysis. BMJ Open, 15(6):e092494. https://doi.org/10.1136/bmjopen-2024-092494

• Wang C, Lai X, Abbas K, Pouwels KB, Zhang H, Jit M, Fang H. (2025). Health impact and economic evaluation of the Expanded Program on Immunization in China from 1974 to 2024: a modelling study. Lancet Public Health, S2468-2667(25)00039-8. https://doi.org/10.1016/s2468-2667(25)00039-8

• Kim S, Kang H, Skrip L, Sahastrabuddhe S, Islam A, Jung SM, Vesga JF, Endo A, Edmunds WJ, Abbas, K. (2025). Progress and challenges in Nipah vaccine development and licensure for epidemic preparedness and response. Expert Review of Vaccines, 24(1), 183–193. https://doi.org/10.1080/14760584.2025.2476523

• Auzenbergs M, Abbas K, Peak CM, Voorman A, Jit M, O’Reilly KM. (2025). Vaccination strategies against wild poliomyelitis in polio-free settings: outbreak risk modelling study and cost-effectiveness analysis. BMJ Global Health, 10(3), e016013. https://doi.org/10.1136/bmjgh-2024-016013

• Bloom D, Cadarette D, Ferranna M, Tortorice D, Excler JL, Mogasale V, Lee JS, Kim S, Abbas K, Wiley R, Mullin A, Walkinshaw D, Williams M, Scarapicchia T, Wright M, Cannon J, Miller K, Giannini F.  (2025). Group A Streptococcus: Full Value of Vaccine Assessment (FVVA) Report. Strep A Vaccine Global Consortium (SAVAC). https://savac.ivi.int/documents/FVVA%20Report_Strep%20A%20Vaccine_27Feb2025_updated.pdf 

2024

• Kang H, Auzenbergs M, Clapham H, Maure C, Kim JH, Salje H, Taylor CG, Lim A, Clark A, Edmunds WJ, Sahastrabuddhe S, Brady OJ, Abbas K. (2024). Chikungunya seroprevalence, force of infection, and prevalence of chronic disability after infection in endemic and epidemic settings: a systematic review, meta-analysis, and modelling study. Lancet Infectious Diseases, 24(5):488-503. https://doi.org/10.1016/S1473-3099(23)00810-1 

• Auzenbergs M, Maure C, Kang H, Clark A, Brady O, Sahastrabuddhe S, Abbas K. (2024). Programmatic considerations and evidence gaps for chikungunya vaccine introduction in countries at risk of chikungunya outbreaks: stakeholder analysis. PLoS Neglected Tropical Diseases, 18(4): e0012075. https://doi.org/10.1371/journal.pntd.0012075 

• Mogasale VV, Sinha A, John J, Hasan Farooqui H, Ray A, Chantler T, Mogasale V, Gopal Dhoubhadel B, John Edmunds W, Clark A, Abbas K. (2024). Research priorities to support typhoid conjugate vaccine decision-making in India: evidence assessment and stakeholder survey. BMJ Public Health, 2:e001089. https://doi.org/10.1136/bmjph-2024-001089  

• Mogasale VV, Sinha A, John J, Hasan Farooqui H, Ray A, Chantler T, Mogasale V, Gopal Dhoubhadel B, John Edmunds W, Clark A, Abbas K. (2024). Typhoid conjugate vaccine implementation in India: A review of supportive evidence. Vaccine X, 21:100568. https://doi.org/10.1016/j.jvacx.2024.100568 

• Williams SV, Akande T, Abbas K. (2024). Systematic review of social determinants of childhood immunisation in low- and middle-income countries and equity impact analysis of childhood vaccination coverage in Nigeria. PLOS One, 19(3):e0297326. https://doi.org/10.1371/journal.pone.0297326 

• Abbas K, Yoo KJ, Prem K, Jit M. (2024). Equity impact of HPV vaccination on lifetime projections of cervical cancer burden among cohorts in 84 countries by global, regional, and income levels, 2010–22: a modelling study. eClinicalMedicine. https://doi.org/10.1016/j.eclinm.2024.102524 

• Hartner AM, Li X, Echeverria-Londono S, Roth J, Abbas K, Auzenbergs M, de Villiers MJ, Ferrari MJ, Fraser K, Fu H, Hallett T, Hinsley W, Jit M, Karachaliou A, Moore SM, Nayagam S, Papadopoulos T, Perkins TA, Portnoy A, Minh QT, Vynnycky E, Winter AK, Burrows H, Chen C, Clapham HE, Deshpande A, Hauryski S, Huber J, Jean K, Kim C, Kim JH, Koh J, Lopman BA, Pitzer VE, Tam Y, Lambach P, Sim SY, Woodruff K, Ferguson NM, Trotter CL, Gaythorpe KAM. (2024).  Estimating the health effects of COVID-19-related immunisation disruptions in 112 countries during 2020-30: a modelling study. Lancet Global Health, 12(4):e563-e571. https://doi.org/10.1016/s2214-109x(23)00603-4  

• Parajulee P, Lee JS, Abbas K, Cannon J, Excler JL, Kim JH, Mogasale V. (2024). State transitions across the Strep A disease spectrum: scoping review and evidence gaps. BMC Infectious Diseases, 24(108). https://doi.org/10.1186/s12879-023-08888-4 

• Maure C, Khazhidinov K, Kang H, Auzenbergs M, Moyersoen P, Abbas K, Santos GML, Medina LMH, Wartel TA, Kim JH, Clemens J, Sahastrabuddhe S. (2024). Chikungunya vaccine development, challenges, and pathway toward public health impact. Vaccine, 42(26), 126483. https://doi.org/10.1016/j.vaccine.2024.126483 

2023

• Kim C, Holm M, Frost I, Hasso-Agopsowicz M, Abbas K. (2023). Global and regional burden of attributable and associated bacterial antimicrobial resistance avertable by vaccination: modelling study. BMJ Global Health, 8:e011341. https://doi.org/10.1136/bmjgh-2022-011341 

• Giannini F, Cannon JW, Cadarette D, Bloom D, Moore H, Carapetis J, Abbas K. (2023). Modeling the potential health impact of prospective Strep A vaccines. NPJ Vaccines, 8(90). https://doi.org/10.1038/s41541-023-00668-0 

• Lee JS, Mogasale V, Kim S, Cannon J, Giannini F, Abbas K, Excler JL, Kim JH. (2023). The potential global cost-effectiveness of prospective Strep A vaccines and associated implementation efforts. NPJ Vaccines, 8(128). https://doi.org/10.1038/s41541-023-00718-7 

• Cadarette D, Ferranna M, Cannon JW, Abbas K, Giannini F, Zucker L, Bloom DE. (2023). The full health, economic, and social benefits of prospective Strep A vaccination. NPJ Vaccines, 8(166). https://doi.org/10.1038/s41541-023-00758-z 

• Fu H, Abbas K, Malvolti S, Gregory C, Ko M, Amorij JP, Jit M. (2023). Impact and cost-effectiveness of measles vaccination through microarray patches in 70 low-income and middle-income countries: mathematical modelling and early-stage economic evaluation. BMJ Global Health, 8:e012204. https://doi.org/10.1136/bmjgh-2023-012204 

• Auzenbergs M, Fu H, Abbas K, Procter SR, Cutts F, Jit M. (2023). Health effects of routine measles vaccination and supplementary immunisation activities in 14 high-burden countries: a Dynamic Measles Immunization Calculation Engine (DynaMICE) modelling study. Lancet Global Health, 11(8):e1194-e1204. https://doi.org/10.1016/s2214-109x(23)00220-6 

• Mwenda V, Jalang’O R, Miano C, Bor JP, Nyangasi M, Mecca L, Were V, Kariithi E, Pecenka C, Schuind A, Abbas K, Clark A. (2023). Impact, cost-effectiveness, and budget implications of HPV vaccination in Kenya: a modelling study. Vaccine, 41(29):4228-4238. https://doi.org/10.1016/j.vaccine.2023.05.019  

• Prem K, Choi YH, Bénard É, Burger EA, Hadley L, Laprise JF, Regan MC, Drolet M, Sy S, Abbas K, Portnoy A, Kim JJ, Brisson M, Jit M. (2023). Global impact and cost-effectiveness of one-dose versus two-dose human papillomavirus vaccination schedules: a comparative modelling analysis. BMC Medicine, 21(313). https://doi.org/10.1186/s12916-023-02988-3 

• Kim C, Goucher GR, Tadesse BT, Lee W, Abbas K, Kim JH. (2023). Associations of water, sanitation, and hygiene with typhoid fever in case-control studies: a systematic review and meta-analysis. BMC Infectious Diseases, 23(562). https://doi.org/10.1186/s12879-023-08452-0